Insights

Clinical-stage leverage Adocia is a clinical-stage biotech developer focused on innovative formulations of approved therapeutic proteins, presenting opportunities to partner on late-stage development, regulatory strategy, or co-development deals to accelerate market entry.

BioChaperone advantage The proprietary BioChaperone platform aims to enhance efficacy and safety of proteins and improve patient usability, suggesting sales potential in partnerships around formulation optimization, device integration, and patient-friendly delivery systems.

Therapeutic focus Specialization in diabetes and obesity positions Adocia to target partnerships with pharma companies seeking adjunctive or improved therapies in these large, high-demand markets.

Funding signals With recent funding of around $56M and modest current revenue, there is appetite for collaboration and licensing deals to de-risk development while expanding market reach.

Growth readiness As a listed company with a pipeline potential and a growth-oriented stance, there are opportunities in strategic collaborations, upfronts, milestone-based financings, and potential commercial partnerships to scale manufacturing and commercialization capabilities.

Similar companies to ADOCIA

ADOCIA Tech Stack

ADOCIA uses 8 technology products and services including Open Graph, WordPress, SAP, and more. Explore ADOCIA's tech stack below.

  • Open Graph
    Content Management System
  • Content Management System
  • Customer Relationship Management
  • Font Awesome
    Font Scripts
  • jQuery
    Javascript Libraries
  • Microsoft Word
    Office Suites
  • Team Collaboration

ADOCIA's Email Address Formats

ADOCIA uses at least 4 email formats:
ADOCIA Email FormatsExamplePercentage
F.Last@adocia.comJ.Doe@adocia.com
85%
First.Last@adocia.comJohn.Doe@adocia.com
7%
Last@adocia.comDoe@adocia.com
6%
First@adocia.comJohn@adocia.com
2%

Frequently Asked Questions

What is ADOCIA's phone number?

Minus sign iconPlus sign icon
You can contact ADOCIA's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is ADOCIA's stock symbol?

Minus sign iconPlus sign icon
ADOCIA is a publicly traded company; the company's stock symbol is ADOC.PA.

What is ADOCIA's official website and social media links?

Minus sign iconPlus sign icon
ADOCIA's official website is adocia.com and has social profiles on LinkedIn and Crunchbase.

How much revenue does ADOCIA generate?

Minus sign iconPlus sign icon
As of August 2026, ADOCIA's annual revenue is estimated to be <$1M.

What is ADOCIA's SIC code and NAICS code?

Minus sign iconPlus sign icon
ADOCIA's SIC code is 8731 - Commercial Physical and Biological Research and NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does ADOCIA have currently?

Minus sign iconPlus sign icon
As of August 2026, ADOCIA has approximately 92 employees across 3 continents, including Europe, North America and South America. Key team members include Chief Financial Officer: V. D., Chief Representative: L. A. and Head Of Business Strategy: J. B. Explore ADOCIA's employee directory with LeadIQ.

What industry does ADOCIA belong to?

Minus sign iconPlus sign icon
ADOCIA operates in the Biotechnology Research industry.

What technology does ADOCIA use?

Minus sign iconPlus sign icon
ADOCIA's tech stack includes Open Graph, WordPress, SAP, Microsoft 365, Font Awesome, jQuery, Microsoft Word and Microsoft Teams.

What is ADOCIA's email format?

Minus sign iconPlus sign icon
ADOCIA's email format typically follows the pattern of F.Last@adocia.com. Find more ADOCIA email formats with LeadIQ.

How much funding has ADOCIA raised to date?

Minus sign iconPlus sign icon
As of August 2026, ADOCIA has raised $56M in funding. The last funding round occurred on Mar 26, 2025 for $10M.

When was ADOCIA founded?

Minus sign iconPlus sign icon
ADOCIA was founded in 2005.
ADOCIA logo

ADOCIA

Biotechnology ResearchAuvergne-Rhône-Alpes, France51-200 Employees

ADOCIA is a clinical-stage biotechnology company based in Lyon, in the Auvergne-Rhône-Alpes region of France and listed on Euronext. It develops medicines by creating new formulations of already approved therapeutic proteins, with a focus on diabetes and obesity. The company relies on a proprietary platform, BioChaperone, to improve the effectiveness, safety, and usability of these proteins for patients.

Its customers are clinicians and patients who would benefit from enhanced therapies built on established biologics. In the biotechnology research landscape, ADOCIA positions itself by advancing reformulations that extend the utility of approved medicines.

Section iconCompany Overview

Phone number
Website
adocia.com
SIC Code
8731 - Commercial Physical and Biological Research
Stock Symbol
ADOC.PA
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2005
Employees
51-200

Section iconFunding & Financials

  • $56M

    ADOCIA has raised a total of $56M of funding over 5 rounds. Their latest funding round was raised on Mar 26, 2025 in the amount of $10M as a Post IPO Equity.

  • <$1M

    ADOCIA's revenue is estimated to be in the range of <$1M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.